Alembic Pharmaceuticals Ltd (APLLTD)

πŸ“Š End of Day Bhavcopy

Date: 2025-09-09

Price: 936.00
% Change: -0.80% (Prev Close: 943.55)

Volume: 73,236
% Change: 50.24% (Prev Volume: 48,747)

Delivery: 25,730
Delivery % : 35.13
% Change: 25.39% (Prev Delivery: 20,520)

Turnover: 689 Lacs
% Change: 49.13% (Prev Turnover: 462)

πŸ’Ή EOD Valuation

P/E Ratio: 30.51
P/B Ratio: 3.54
Market Cap: 18402 Rs. Cr.

Fundamental Data

Date: 05-09-2025

🏷️ Company Basics

Symbol: APLLTD
Market Cap: 18417 Rs. Cr.
Face Value: 2.00 Rs.

52 Week High: 1303.90
52 Week Low: 725.20

All-Time High: 1303.90 Rs.
All-Time Low: 31.00 Rs.

Stock Price Increase (% Return) %

% Return (1 mth |3 mth | 6 mth | 1 Yr | 3 Yrs | 5 Yrs):
0.98% | -3.22% | 13.15% | -14.37% | 14.30%

πŸ‘₯ Shareholding Pattern

Promoter Holding

Promoter Holding: 69.67%

Change (3Y | 1Y): 0.06% | 0.00%

Pledged %: 0.00%

FII Holding

FII Holding: 3.96%

Change (3Y | 1Y): -1.98% | 0.02%

DII Holding

DII Holding: 16.46%

Change (3Y | 1Y): 4.31% | 0.03%

Public Holding: 9.91%

🏦 Financial Strength

Debt to Equity: 0.24
Debt: 1257.50 Rs. Cr.

Book Value: 264.09 Rs.
Current Ratio: 1.69
Interest Coverage: 9.16
Free Cash Flow: -465.90 Rs. Cr.

πŸ“ˆ Growth & Sales

Sales Growth: 8.20%

Sales Growth Qtr (YOY | QoQ):
9.54% | -3.33%

Sales Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
7.69% | 7.94% | 8.20%

πŸ’° Profit & Earnings

Profit Growth %

Profit Growth: -5.85%

Profit Growth Qtr (YOY | QoQ):
14.60% | -1.92%

Profit Growth Yrs. (5 Yrs | 3 Yrs | 1 Yr):
-7.96% | 3.18% | -5.85%

EPS Rs.

EPS (TTM): 30.68 Rs.

EPS Qtr (Last Year | Latest):
6.85 Rs. | 7.85 Rs.

EPS Annual (Last Annual | Annual March):
31.33 Rs. | 29.68 Rs.

EPS Growth Variation % (5 Yrs | 3 Yrs):
-8.73% | 3.18%

Net Profit Rs. Cr.

Net Profit (TTM): 601.10 Rs. Cr.

Net Profit (Annual - March): 582.01 Rs. Cr.

Net Profit Qtr (Last Year Q | Previous Q | Latest Q):
134.54| 156.63 | 153.63

EBITDA Rs. Cr.

EBITDA (Quarter): 287.40 Rs. Cr.
EBITDA (Previous Yr Ql): 239.25 Rs. Cr.

EBITDA (Annual - March): 1047.34 Rs. Cr.
EBITDA (Previous Annual): 957.36 Rs. Cr.

EBITDA (5 Yrs | 3 Yrs) %:
-3.10% | 4.17%

πŸ“Š Profitability Ratios

Operating Margin (OPM)

OPM (TTM): 15.42%

OPM Qtr (Previous | Current):
15.33% | 16.42%

OPM Annual (5 Yrs | Last Yr | March):
17.01% | 14.97% | 15.11%

Return on Equity %

ROE: 11.38%

ROE (5 Yrs | 3 Yrs | Last Yr):
13.45% | 10.61% | 13.34%

Return on Capital Employed %

ROCE: 13.05%

ROCE (5 Yrs | 3 Yrs | Last Yr):
14.13% | 11.20% | 13.14%

Return on Assets %

ROA (TTM): 7.99%

ROA (5 Yrs | 3 Yrs | Last Yr):
9.67% | 7.63% | 9.71%

PEG Ratio: 9.76
Dividend Yield: 1.17%

PE 3 Yrs: 33.33
PE 5 Yrs: 29.07

Dividend Yield: 1.17%

πŸ‘₯ Company

Alembic Pharmaceuticals Ltd

APLLTD

Promoter Holding: %